Novacyt S.A. (ALNOV.PA)

EUR 0.49

(-2.2%)

Total Assets Summary of Novacyt S.A.

Novacyt S.A.'s latest annual total assets in 2023 was 133.81 Million GBP , down -5.03% from previous year.
Novacyt S.A.'s latest quarterly total assets in 2023 FY was 133.81 Million GBP , down -5.03% from previous quarter.
Novacyt S.A. reported annual total assets of 140.9 Million GBP in 2022, down -23.3% from previous year.
Novacyt S.A. reported annual total assets of 183.69 Million GBP in 2021, down -21.59% from previous year.
Novacyt S.A. reported quarterly total assets of 150.29 Million GBP for 2023 Q1, up 6.67% from previous quarter.
Novacyt S.A. reported quarterly total assets of 132.14 Million GBP for 2023 Q2, down -12.07% from previous quarter.

Annual Total Assets Chart of Novacyt S.A. (2023 - 2011)

Historical Annual Total Assets of Novacyt S.A. (2023 - 2011)

Year	Total Assets	Total Assets Growth
2023	133.81 Million GBP	-5.03%
2022	140.9 Million GBP	-23.3%
2021	183.69 Million GBP	-21.59%
2020	234.27 Million GBP	782.73%
2019	26.53 Million EUR	-9.45%
2018	29.31 Million EUR	-2.96%
2017	30.2 Million EUR	16.4%
2016	25.94 Million EUR	105.56%
2015	12.62 Million EUR	-39.23%
2014	20.77 Million EUR	680.1%
2013	2.66 Million EUR	-19.3%
2012	3.29 Million EUR	162.0%
2011	1.25 Million EUR	0.0%

Year	Total Assets	Total Assets Growth
2023 FY	133.81 Million GBP	-5.03%
2023 Q1	150.29 Million GBP	6.67%
2023 Q2	132.14 Million GBP	-12.07%
2023 Q4	133.81 Million GBP	0.0%
2022 Q4	140.9 Million GBP	-12.25%
2022 Q2	166.12 Million GBP	0.0%
2022 FY	140.9 Million GBP	-23.3%
2022 Q3	160.57 Million GBP	-3.35%
2021 Q2	182.17 Million GBP	0.0%
2021 FY	183.69 Million GBP	-21.59%
2021 Q4	183.69 Million GBP	0.0%
2020 Q2	80.38 Million EUR	0.0%
2020 Q4	234.27 Million GBP	0.0%
2020 FY	234.27 Million GBP	782.73%
2019 FY	26.53 Million EUR	-9.45%
2019 Q2	30.61 Million EUR	0.0%
2019 Q4	31.06 Million EUR	0.0%
2018 Q4	29.31 Million EUR	0.0%
2018 FY	29.31 Million EUR	-2.96%
2018 Q2	30.73 Million EUR	0.0%
2017 Q4	30.2 Million EUR	0.0%
2017 FY	30.2 Million EUR	16.4%
2017 Q2	27.55 Million EUR	0.0%
2016 Q4	25.94 Million EUR	0.0%
2016 FY	25.94 Million EUR	105.56%
2016 Q2	24.94 Million EUR	0.0%
2015 Q4	12.62 Million EUR	0.0%
2015 Q2	17.79 Million EUR	0.0%
2015 FY	12.62 Million EUR	-39.23%
2014 Q2	21.28 Million EUR	0.0%
2014 Q4	20.77 Million EUR	0.0%
2014 FY	20.77 Million EUR	680.1%
2013 FY	2.66 Million EUR	-19.3%
2012 FY	3.29 Million EUR	162.0%
2011 FY	1.25 Million EUR	0.0%

Peer Total Assets Comparison of Novacyt S.A.

Name	Total Assets	Total Assets Difference
Affluent Medical SA	56.62 Million EUR	-136.326%
Bluelinea Société Anonyme	13.16 Million EUR	-916.466%
Carmat SA	53.06 Million EUR	-152.153%
Diagnostic Medical Systems S.A.	51.13 Million EUR	-161.674%
Euromedis Groupe	46.25 Million EUR	-189.277%
Eurobio Scientific Société anonyme	315.81 Million EUR	57.629%
Ikonisys S.A.	20.85 Million EUR	-541.719%
Implanet S.A.	10.63 Million EUR	-1158.014%
Median Technologies SA	35.81 Million EUR	-273.66%
SpineGuard SA	11.03 Million EUR	-1112.603%
Theraclion SA	18.66 Million EUR	-616.985%
Euroapi S.A.	1.61 Billion EUR	91.701%
Guerbet SA	1.02 Billion EUR	86.948%